SCHEMBL6578845

SCHEMBL6578845

CC(C)(C)[Si](C)(C)OCCOCCOS(=O)(=O)C(F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
DUT P33316 1/20 0.38
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL578097 0.95 CA2 (0.35) DUTCA1CA2
SCHEMBL6655379 0.85 DUT (0.35) DUTCA1CA2
SCHEMBL6577285 0.83 DUT (0.35) DUTCA1CA2
SCHEMBL16898660 0.81 DUT (0.40) DUTCA1CA2
SCHEMBL31171203 0.81 DUT (0.40) DUTCA1CA2
SCHEMBL12013275 0.81 DUT (0.40) DUTCA1CA2
SCHEMBL4949086 0.80 CA2 (0.43) CA1CA2
SCHEMBL4949681 0.80 CA2 (0.43) CA1CA2
SCHEMBL4953881 0.80 CA2 (0.43) CA1CA2
SCHEMBL11903406 0.79 CA1 (0.32) CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0867438-B1 Rapamycin derivatives and their use, particularly as immunosuppressants NOVARTIS AG (CH) 2004-07-28 EP disclosed
EP-1413581-A1 Rapamycin derivatives Novartis AG (CH) 2004-04-28 EP disclosed
EP-0867438-A1 Rapamycin derivatives and their use, particularly as immunosuppressants Novartis AG (CH) 1998-09-30 EP disclosed
US-5665772-A O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants SANDOZ LTD. (CH) 1997-09-09 US disclosed
EP-0663916-A1 O-ALKYLATED RAPAMYCIN DERIVATIVES AND THEIR USE, PARTICULARLY AS IMMUNOSUPPRESSANTS SANDOZ-ERFINDUNGEN Verwaltungsgesellschaft m.b.H. (AT) 1995-07-26 EP disclosed
WO-1994009010-A1 O-ALKYLATED RAPAMYCIN DERIVATIVES AND THEIR USE, PARTICULARLY AS IMMUNOSUPPRESSANTS SANDOZ LTD. (CH) 1994-04-28 WO disclosed